| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |